Kate Kucharzyk is Cleaning Up at Work

Posted by Battelle Insider on Sep 25, 2017

Kate Kucharzyk is leading efforts to expand Battelle’s metagenomic and proteomics capabilities for environmental clients.

Behind the Study: Investigate the MPS Feasibility and Guidance Report

Posted by Battelle Insider on Sep 18, 2017

After an exhaustive 19-month research project, massively parallel sequencing is proven to generate robust, reliable, reproducible results.

3 Innovations Improving Safety Pharmacology Testing

Posted by Battelle Insider on Sep 11, 2017

Toxicology safety testing teams are under more pressure than ever. Here are three significant innovations helping tox teams achieve more success.

An Action-Packed End to Summer at Battelle

Posted by Battelle Insider on Sep 7, 2017

The end of August brings more than just a holiday weekend and reminders that fall is fast approaching. For Battelle, it meant a very busy week.

Bringing Down Barriers to Medical Countermeasure Development

Posted by Russell Coleman on Aug 29, 2017

To meet the need for new vaccines for chemical & biological weapons, federal agencies & private companies must work together to overcome barriers.

Med Device Culture Shift: Designing to Expect an Attack

Posted by Battelle Insider on Aug 22, 2017

Connected devices and cybersecurity for those devices are new concepts – ones that typically falls out of the wheelhouse of the device manufacture.

What the MPS Feasibility Report Means for Forensic Science Today

Posted by Battelle Insider on Aug 17, 2017

Massively Parallel Sequencing has been the talk of DNA scientists, but now it’s closer than ever to becoming a valid asset for law enforcement.